Management of chronic shoulder pain in adults with individualized homoeopathic medicines: A double-blind, randomized, placebo-controlled trial - NA

D. N. De Homoeopathic Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月29日

试验速览

暂无简介。

•1. Patients with chronic shoulder pain for 3 months or more according to ICD 10 (M25.51)
•2. Patients already undergoing regular oral or topical analgesics or NSAID therapy for chronic shoulder pain, provided the medications are stopped completely at least 2 weeks prior study entry
•3. Age between 18 and 65 years
•4. Patients of either both sex and transgender
•5. Participants having prior experience or knowledge of the treatment; e.g., primed to expect ‘homoeopathic aggravation’ and available treatment options for the disease conditions, intimated through Patient Information Sheet.

•1. Not providing informed consent of participation
•2. Radiological evidence of shoulder joint fracture or dislocation
•3. Non-ambulant patients
•4. Intra-articular injections within 2 weeks before study entry
•5. Cases willing for or requiring immediate surgical intervention or already underwent any major shoulder joint surgery within last 3 months, 6. When the shoulder pain is due to any invasive malignant disease or neoplasia
•7. Patients suffering from active local infection of shoulder joint, 8.Patients who are too sick for consultation
•8. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life
•9. Pregnancy, puerperal women and lactating mother
•10. Tobacco chewing and/or smoking, alcoholism and/or any form(s) of substance abuse and/or dependence (TAPS tool)
•11. Self-reported immune-compromised state, AIDS, hepatitis etc.
•12. Undergoing homoeopathic treatment for any chronic disease within last 6 months
•13. Simultaneous participation in any other clinical trial

发起方

D. N. De Homoeopathic Medical College and Hospital